Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Audio Interview: Caring for Hospitalized Patients with Covid-19.

The New England journal of medicine·2022

Same author

Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.

The New England journal of medicine·2022

Same author

Audio Interview: Covid-19: Where Are We Heading?

The New England journal of medicine·2022

Same author

Audio Interview: Developing New Covid-19 Vaccines.

The New England journal of medicine·2022

Same author

Audio Interview: Infectious Disease in Africa.

The New England journal of medicine·2022

Same author

Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in <i>Mycobacterium tuberculosis</i>.

Frontiers in cellular and infection microbiology·2022

Search research articles

Related Experiment Video

Updated: Feb 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis: Just the FAQs.

Kristine M Guinn¹, Eric J Rubin²

¹Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.

|December 21, 2017

Summary

This summary is machine-generated.

Tuberculosis (TB) remains a leading infectious cause of death globally. This review uses a FAQ format to explore current knowledge gaps and the translation of laboratory findings to human TB understanding.

Keywords:

infectious disease public health tuberculosis

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Related Experiment Videos

Last Updated: Feb 16, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

Published on: April 9, 2012

Area of Science:

Infectious Diseases
Microbiology
Public Health

Background:

Tuberculosis (TB) is a significant global health challenge, causing more deaths than any other infectious disease.
Understanding the complexities of TB is crucial for effective public health strategies.
The gap between laboratory research and clinical application in TB remains a critical area of investigation.

Purpose of the Study:

To provide a comprehensive overview of current knowledge regarding tuberculosis.
To address frequently asked questions about TB, bridging the gap between research and clinical understanding.
To critically evaluate the utility of laboratory findings in informing the understanding of human tuberculosis.

Main Methods:

A review of existing literature and research findings on tuberculosis.
A question-and-answer format to address common queries about TB.
Critical analysis of the translation of basic science discoveries to clinical relevance for human TB.

Main Results:

Identifies key areas where knowledge of human tuberculosis is lacking.
Highlights the limitations of current laboratory models in fully explaining human TB.
Discusses the ongoing challenges in translating research into effective clinical interventions.

Conclusions:

Further research is needed to bridge the gap between laboratory findings and human tuberculosis.
A deeper understanding of the human host-pathogen interaction is essential for TB control.
Translational research efforts must be prioritized to combat this persistent public health threat.